• Issue

    American Journal of Hematology: Volume 85, Issue 9

    641-735
    September 2010
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Editorial Perspectives

Free Access

A possible new role for Helicobacter pylori in the development of ocular adnexal lymphoma†

Sarah E. Coupland, 
  • Pages: 641-642
  • First Published: 25 August 2010
Free Access

On the relative safety of intravenous iron formulations: New answers, new questions†

Glenn M. Chertow,  Wolfgang C. Winkelmayer MD, MPH, ScD, 
  • Pages: 643-644
  • First Published: 25 August 2010

Original Articles

Free Access

Ocular adnexal lymphoma and Helicobacter pylori gastric infection†

Didier Decaudin,  Agnès Ferroni,  Anne Vincent-Salomon,  Kheira Beldjord,  Pierre Validire,  Patricia de Cremoux,  Patricia Validire,  Corine Plancher,  Claire Mathiot,  Elizabeth Macintyre,  Bernard Asselain,  Jacques Girodet,  Frédéric Mal,  Nicole Brousse,  Jean-Luc Beretti,  Rémi Dendale,  Livia Lumbroso-Le Rouic,  Olivier Hermine,  Marc Lecuit, 
  • Pages: 645-649
  • First Published: 25 August 2010
Free Access

Use of parenteral iron products and serious anaphylactic-type reactions†‡ §

Diane K. Wysowski,  Lynette Swartz,  B. Vicky Borders-Hemphill,  Margie R. Goulding,  Catherine Dormitzer, 
  • Pages: 650-654
  • First Published: 25 August 2010
Free Access

Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy-induced anemia†

Michael Auerbach,  Peter T. Silberstein,  R. Timothy Webb,  Svetlana Averyanova,  Tudor-Eliade Ciuleanu,  James Shao,  Kenneth Bridges, 
  • Pages: 655-663
  • First Published: 25 August 2010
Free Access

Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma

Francesca Gay,  S. Vincent Rajkumar,  Morton Coleman,  Shaji Kumar,  Tomer Mark,  Angela Dispenzieri,  Roger Pearse,  Morie A. Gertz,  John Leonard,  Martha Q. Lacy,  Selina Chen-Kiang,  Vivek Roy,  David S. Jayabalan,  John A. Lust,  Thomas E. Witzig,  Rafael Fonseca,  Robert A. Kyle,  Philip R. Greipp,  A. Keith Stewart,  Ruben Niesvizky, 
  • Pages: 664-669
  • First Published: 25 August 2010
Free Access

Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia

Irene M. Ghobrial,  Wanling Xie,  Swaminathan Padmanabhan,  Ashraf Badros,  Meghan Rourke,  Renee Leduc,  Stacey Chuma,  Janet Kunsman,  Diane Warren,  Tiffany Poon,  Brianna Harris,  Amy Sam,  Kenneth C. Anderson,  Paul G. Richardson,  Steven P. Treon,  Edie Weller,  Jeffrey Matous, 
  • Pages: 670-674
  • First Published: 25 August 2010
Free Access

TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells†

Vijay Ramakrishnan,  Teresa Kimlinger,  Jessica Haug,  Michael Timm,  Linda Wellik,  Timothy Halling,  Animesh Pardanani,  Ayalew Tefferi,  Sundararasan Vincent Rajkumar,  Shaji Kumar, 
  • Pages: 675-686
  • First Published: 25 August 2010
Free Access

Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: Feasibility, toxicity, and therapeutic results†

Felicetto Ferrara,  Tiziana Izzo,  Clelia Criscuolo,  Cira Riccardi,  Maria Celentano,  Giuseppina Mele, 
  • Pages: 687-690
  • First Published: 25 August 2010
Free Access

Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC†

Hideo Wada,  Tsuyoshi Hatada,  Kohji Okamoto,  Toshimasa Uchiyama,  Kazuo Kawasugi,  Toshihiko Mayumi,  Satoshi Gando,  Shigeki Kushimoto,  Yoshinobu Seki,  Seiji Madoiwa,  Takashi Okamura,  Cheng Hock Toh, 
  • Pages: 691-694
  • First Published: 25 August 2010
Free Access

Invasive fungal disease in patients treated for newly diagnosed acute leukemia†‡

Sarah P. Hammond,  Francisco M. Marty,  Julie M. Bryar,  Daniel J. DeAngelo,  Lindsey R. Baden, 
  • Pages: 695-699
  • First Published: 25 August 2010

Critical Reviews

Free Access

Heparin-induced thrombocytopenia: Current status and diagnostic challenges†

Stavroula A Otis,  James L. Zehnder, 
  • Pages: 700-706
  • First Published: 25 August 2010

Clinical Pearls in Blood Diseases

Morphology Update

Free Access

Neutrophil dysplasia demonstrated on Sudan black B staining†

Barbara J. Bain, 
  • Page: 707
  • First Published: 25 August 2010

Solving Clinical Problems

Free Access

Coagulopathy in a patient with nephrotic syndrome†‡

Shari Ghanny,  Catherine Ross,  Anthony K.C. Chan,  Howard H.W. Chan, 
  • Pages: 708-710
  • First Published: 25 August 2010

Images in Hematology

Free Access

Resolution of massive pleural effusion due to lymphoma with intrapleural interleukin-2†

Dahlia Elkadi,  Peter H. Wiernik,  Tommy R. Tong, 
  • Pages: 711-712
  • First Published: 25 August 2010

Diagnostic Imaging in Hematology

Free Access

Necrosis following skull base irradiation and stem cell transplant for multiple myeloma†

Sonia Skamene,  Ronny L. Rotondo,  Chaim Shustik,  David Roberge, 
  • Pages: 713-714
  • First Published: 25 August 2010

Letters

Free Access

Effective management of accelerated phase myelofibrosis with low-dose splenic radiotherapy†

A. Pardanani,  P. Brown,  M. Neben-Wittich,  R. Tobin,  A. Tefferi, 
  • Pages: 715-716
  • First Published: 25 August 2010
Free Access

Alteration of cohesin genes in myeloid diseases†

Julien Rocquain,  Véronique Gelsi-Boyer,  José Adélaïde,  Anne Murati,  Nadine Carbuccia,  Norbert Vey,  Daniel Birnbaum,  Marie-Joelle Mozziconacci,  Max Chaffanet, 
  • Pages: 717-719
  • First Published: 25 August 2010
Free Access

Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis†

Jae-Sook Ahn,  Sung-Yoon Rew,  Myung-Geun Shin,  Hye-Ran Kim,  Deok-Hwan Yang,  Duck Cho,  Soo-Hyun Kim,  Soo Young Bae,  Se Ryeon Lee,  Yeo-Kyeoung Kim,  Hyeoung-Joon Kim,  Je-Jung Lee, 
  • Pages: 719-722
  • First Published: 25 August 2010
Free Access

Acute life-threatening cardiovascular toxicity with umbilical cord blood infusion: The role of dextran†

Robert W. Ma,  John M. Kwan,  David D. Ma,  Keith C. Fay, 
  • Pages: 722-724
  • First Published: 25 August 2010
Free Access

Acute renal failure in a patient with antiphospholipid syndrome and immune thrombocytopenic purpura treated with eltrombopag†

C. John Sperati,  Michael B. Streiff, 
  • Pages: 724-726
  • First Published: 25 August 2010
Free Access

Screening coagulation testing using the APTT: Which reagent to choose?†

Francine R. Dembitzer,  Yvelisse Suarez,  Louis M. Aledort,  Ellinor I.B. Peerschke, 
  • Page: 726
  • First Published: 25 August 2010
Free Access

Hepatosplenic T cell lymphoma responsive to 2′-deoxycoformycin therapy†

Michael Bennett,  Estella Matutes,  Philippe Gaulard, 
  • Pages: 727-729
  • First Published: 25 August 2010
Free Access

Acute leukemia presenting with extramedullary diseases and completely normal hemogram: An extremely unusual manifestation unique to pre-B ALL†

Chih-Cheng Chen,  Hsu-Huei Weng,  Cih-En Hwang,  Chang-Hsien Lu,  Ping-Tsung Chen,  Jyh-Pyng Gau, 
  • Pages: 729-731
  • First Published: 25 August 2010
Free Access

Hemoglobin disorders in the developing world: A perspective from Sri Lanka†

Vijay G. Sankaran, 
  • Page: 732
  • First Published: 25 August 2010
Free Access

Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen†

Edward Libby,  Dulcinea Candelaria-Quintana,  Hayan Moualla,  Maryam Abdul-Jaleel,  Ian Rabinowitz, 
  • Pages: 733-734
  • First Published: 25 August 2010

Crossword Puzzle

Free Access

August crossword answers

  • Page: 735
  • First Published: 25 August 2010